Correlation Between Exxon and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Exxon and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exxon and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exxon Mobil Corp and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Exxon and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exxon with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exxon and Neurobo Pharmaceuticals.
Diversification Opportunities for Exxon and Neurobo Pharmaceuticals
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Exxon and Neurobo is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Exxon Mobil Corp and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Exxon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exxon Mobil Corp are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Exxon i.e., Exxon and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Exxon and Neurobo Pharmaceuticals
Considering the 90-day investment horizon Exxon Mobil Corp is expected to generate 0.26 times more return on investment than Neurobo Pharmaceuticals. However, Exxon Mobil Corp is 3.86 times less risky than Neurobo Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest 11,929 in Exxon Mobil Corp on August 24, 2024 and sell it today you would earn a total of 264.00 from holding Exxon Mobil Corp or generate 2.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Exxon Mobil Corp vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Exxon Mobil Corp |
| Neurobo Pharmaceuticals |
Exxon and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Exxon and Neurobo Pharmaceuticals
The main advantage of trading using opposite Exxon and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exxon position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Exxon vs. Shell PLC ADR | Exxon vs. BP PLC ADR | Exxon vs. Suncor Energy | Exxon vs. Petroleo Brasileiro Petrobras |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |